Equity Profile

CRL

Charles River Laboratories International, Inc.

Health CareLife Sciences Tools & Services$8.7B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Charles River Laboratories International, Inc. (CRL) operates in the health care sector, specifically in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, and investors will be looking for continued growth.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is critical in the competitive life sciences sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRL Q2-2026 Earnings Preview

Context

Company Snapshot

Charles River Laboratories International, Inc. (CRL) operates in the health care sector, specifically in life sciences tools and services. The company plays a crucial role in supporting the pharmaceutical and biotechnology industries by providing essential services for drug development and testing, which are vital for bringing new therapies to market.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.31%

Avg Stock Reaction

+1.27%

Last Quarter Recap

In Q1-2026, CRL reported an EPS of $2.06, beating estimates by 5.21%. However, the stock experienced a slight decline the following day, indicating market caution despite the positive earnings surprise.

Management Promises & Guidance

Continued focus on expanding service offerings in drug development.
Commitment to maintaining high client satisfaction and retention.
Plans to invest in new technologies to enhance service efficiency.

Expectations

Wall Street Expectations

Overall, expectations are mixed as CRL has a strong track record of beating EPS estimates, but the stock has reacted negatively in the past despite positive earnings.

Bull Case

If CRL continues its trend of beating EPS estimates and demonstrates strong revenue growth, it could lead to a positive market reaction and renewed investor confidence.

Bear Case

On the other hand, if the company fails to meet expectations or provides cautious guidance, it could lead to further declines in stock price, especially given the recent negative reactions to earnings surprises.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

Given CRL's history of beating EPS estimates, the market will closely watch this figure to gauge the company's ongoing profitability.

What is the outlook for revenue growth in the upcoming quarters?

Revenue growth is crucial for CRL's future performance, and any guidance provided will significantly impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CRL's potential for revenue growth due to its ongoing investments in new technologies and service offerings.

Supporting Evidence

CRL has consistently beaten EPS estimates, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting heightened volatility that may not reflect underlying fundamentals.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on CRL's ability to maintain its growth trajectory and profitability amidst market challenges.

Bull Confirmed If

An EPS of $2.20 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $1.90 would confirm the bear case, suggesting potential issues in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.0%

Historical Avg

±8.5%

Pricing rich

The options market is pricing in a significant move of around 10% in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±10.0% while CRL has averaged ±8.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

60.1%

Calls (154K)P/C Ratio: 1.46Puts (22K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CRL beats expectations and raises guidance, history suggests the stock could rise by around 1.27% on the following day, confirming market confidence.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction as investors weigh future growth prospects.

Miss

A miss on EPS could lead to a decline of around 5.71%, reflecting market disappointment and concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings and their expected impact on revenue.
2Insights into client retention rates and customer satisfaction metrics.
3Management's commentary on market conditions and competitive landscape.
4Guidance on future revenue growth and profitability targets.
5Details on investments in technology and their anticipated benefits.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Charles River Laboratories International, Inc. (CRL) operates in the health care sector, specifically in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, and investors will be looking for continued growth.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is critical in the competitive life sciences sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRL Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.31%

Avg Stock Reaction

+1.27%

Last Quarter Recap

Management Promises & Guidance

Continued focus on expanding service offerings in drug development.
Commitment to maintaining high client satisfaction and retention.
Plans to invest in new technologies to enhance service efficiency.

Expectations

Wall Street Expectations

Overall, expectations are mixed as CRL has a strong track record of beating EPS estimates, but the stock has reacted negatively in the past despite positive earnings.

Bull Case

If CRL continues its trend of beating EPS estimates and demonstrates strong revenue growth, it could lead to a positive market reaction and renewed investor confidence.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

Given CRL's history of beating EPS estimates, the market will closely watch this figure to gauge the company's ongoing profitability.

What is the outlook for revenue growth in the upcoming quarters?

Revenue growth is crucial for CRL's future performance, and any guidance provided will significantly impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CRL's potential for revenue growth due to its ongoing investments in new technologies and service offerings.

Supporting Evidence

CRL has consistently beaten EPS estimates, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting heightened volatility that may not reflect underlying fundamentals.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on CRL's ability to maintain its growth trajectory and profitability amidst market challenges.

Bull Confirmed If

An EPS of $2.20 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $1.90 would confirm the bear case, suggesting potential issues in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.0%

Historical Avg

±8.5%

Pricing rich

The options market is pricing in a significant move of around 10% in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±10.0% while CRL has averaged ±8.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

60.1%

Calls (154K)P/C Ratio: 1.46Puts (22K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CRL beats expectations and raises guidance, history suggests the stock could rise by around 1.27% on the following day, confirming market confidence.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction as investors weigh future growth prospects.

Miss

A miss on EPS could lead to a decline of around 5.71%, reflecting market disappointment and concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings and their expected impact on revenue.
2Insights into client retention rates and customer satisfaction metrics.
3Management's commentary on market conditions and competitive landscape.
4Guidance on future revenue growth and profitability targets.
5Details on investments in technology and their anticipated benefits.